Skip to main content
PLOS One logoLink to PLOS One
. 2020 Jul 23;15(7):e0236620. doi: 10.1371/journal.pone.0236620

Reproduction ratio and growth rates: Measures for an unfolding pandemic

Maíra Aguiar 1,2,3,*,#, Joseba Bidaurrazaga Van-Dierdonck 4,#, Nico Stollenwerk 1,5,#
Editor: Constantinos Siettos6
PMCID: PMC7377402  PMID: 32702051

Abstract

The initial exponential growth rate of an epidemic is an important measure that follows directly from data at hand, commonly used to infer the basic reproduction number. As the growth rates λ(t) of tested positive COVID-19 cases have crossed the threshold in many countries, with negative numbers as surrogate for disease transmission deceleration, lockdowns lifting are linked to the behavior of the momentary reproduction numbers r(t), often called R0. Important to note that this concept alone can be easily misinterpreted as it is bound to many internal assumptions of the underlying model and significantly affected by the assumed recovery period. Here we present our experience, as part of the Basque Country Modeling Task Force (BMTF), in monitoring the development of the COVID-19 epidemic, by considering not only the behaviour of r(t) estimated for the new tested positive cases—significantly affected by the increased testing capacities, but also the momentary growth rates for hospitalizations, ICU admissions, deceased and recovered cases, in assisting the Basque Health Managers and the Basque Government during the lockdown lifting measures. Two different data sets, collected and then refined during the COVID-19 responses, are used as an exercise to estimate the momentary growth rates and reproduction numbers over time in the Basque Country, and the implications of using those concepts to make decisions about easing lockdown and relaxing social distancing measures are discussed. These results are potentially helpful for task forces around the globe which are now struggling to provide real scientific advice for health managers and governments while the lockdown measures are relaxed.

Introduction

As the COVID-19 pandemic is unfolding, research on mathematical modeling became imperative and very influential, not only in understanding the epidemiology of COVID-19 but also in helping the national health systems to cope with the high demands of hospitalizations, for example, providing projections and predictions based on the available data. Used as public health guiding tools to evaluate the impact of intervention measures, governments have already taken important decisions based on modeling results [13].

While for diseases which are long established, such as measles [4], e.g., modeling results are easier to be interpreted, given the availability of long term and well established data collections, and public health interventions, counting with an effective vaccine, are able to be be implemented in time to avoid large outbreaks. For COVID-19 the situation is completely different. We are now dealing with a single disease outbreak in a pandemic scenario and modeling projections, for instance, need to be adjusted for the new scientific information and new data that are generated every day under unprecedentedly fast changes of circumstances. Governments around the globe are relying on quick measurements updates and long established concepts such as the reproduction numbers which are bound to too many internal assumptions of the underlying model, smoothing and approximations [5] and significantly affected by the assumed recovery period.

The initial exponential growth rate of an epidemic is an important measure that follows directly from data at hand, commonly used to infer the basic reproduction number R0, which is the number of secondary cases generated from a primary infected case during its infectiousness before recovering in a completely susceptible population [6]. Both concepts can be extended to larger compartmental models and into the phase when effects of the control measures become visible and parameters slowly change, leading to the so called momentary growth rates λ(t), and momentary reproduction ratios r(t).

In the beginning of COVID-19 epidemics, the process of collecting data were often not yet well organized or pre-organized in the way that we could immediately use to feed models and extract accurate measurements for the momentary growth rates and the momentary reproduction numbers. To mitigate and suppress COVID-19 transmission, draconian intervention measures were rapidly implemented, crippling our economies as lockdowns were implemented. As research to develop an effective vaccine is ongoing, epidemiologists and public health workers are the frontline of this pandemic, focusing on the well known public health surveillance strategies of testing, isolation and contact tracing of infected COVID-19 individuals. Up to date, more than 4 million cases were confirmed with about 300 thousand deaths, and these numbers are still increasing [7].

After several weeks of social distancing restrictions, lockdowns start now to be lifted and modeling task forces around the globe are struggling to apply the concept of r(t), often called R0, to decide whether social distancing relaxation decisions are taken in the right period of time, i.e, when the outbreak is assumed to be controlled, with negative growth rates and a momentary reproduction numbers below 1. Although the absolute value of r(t) can vary given the modeling assumptions considered during its estimation, it is advised to rather look at the threshold behavior, using the growth rates primarily as it is independent of modeling uncertainties and clearly indicates if the outbreak is under control or not when estimations are below or above threshold. Complementary measures of growth rates for different variables such as hospitalization, intensive care units (ICU) admissions and deceased, where data is also collected, should be evaluated when political decisions are taken.

In this paper we present the growth rates and reproduction numbers for the COVID-19 epidemic in the Basque Country, an autonomous community in northern Spain with 2.2 million inhabitants. For the reproduction number calculation we use a refined stochastic SHARUCD-type model—an extension of the well known simple SIR model that is frequently used to model different disease outbreaks [810], developed within a multidisciplinary task force (so-called Basque Modelling Task Force, BMTF) created to assist the Basque Health managers and the Basque Government during the COVID-19 responses. The model is calibrated using the empirical data provided by the Basque Health Department and the Basque Health Service (Osakidetza), continually collected with specific inclusion and exclusion criteria. Able to describe well the incidences of disease for different variables of tested positive individuals (see Fig 1), this framework is now used to monitor disease transmission, including estimations of the momentary growth rates and reproduction numbers, while the country lockdown is gradually lifted [11]. Using two different available data sets for the Basque Country, collected from March 4 to May 9, 2020, the data was revised with a change on the variable definition for positive cases in respect to the diagnostic test used. We present results obtained for the momentary growth rates and reproduction ratios during the ongoing COVID-19 epidemic in the Basque Country and discuss the implications of using those concepts during an unfolding pandemic.

Fig 1. Ensemble of 200 stochastic realizations of the SHARUCD-type model.

Fig 1

Mean of the stochastic realizations is shown with a blue line. In a) Cumulative tested positive cases Icum(t). Data set From April 6, 2020, we note an increase of reported positive cases as the testing capacities were increasing. In b) cumulative hospitalized cases CH(t), c) cumulative ICU admission CU(t), d) cumulative deceased cases D(t). For reference, “Data set A” is plotted as black dots in a-c) and red dots in d). “Data set B” is plotted as blue dots in a). Empirical data was provided by the Basque Health Department and the Basque Health Service (Osakidetza).

Materials and methods

For the Basque Country we use the cumulative data for the following variables defined as: i) total tested positive patients (Icum) which are recorded in categories for ii) hospital admissions (CH), iii) intensive care units admissions (CU), iv) recovered (CR) and v) deceased (D). At the beginning of the outbreak, only patients with severe symptoms admitted to a hospital were tested using the PCR (polymerase chain reaction) method. As testing capacities increased, including also antibody tests used mainly as screening tool in nursing homes, less severe symptomatic cases started to be tested, contributing to enhance the number of confirmed positive cases in the population. This data collection (named “Data set A”) includes, for each category or variable, patients tested with both PCR and rapid antibody tests. “Data set A” has now being revised to include patiences, in all categories, who were tested positive with PCR method only (named “Data set B”). Using the data for the all positive cases, the momentary growth rates (λ) and the momentary reproduction numbers (r(t)) are calculated for both data sets, A and B, and results are compared.

0.1 The underlying mathematical model and empirical data

We use SHARUCD-type models, an extension of the well known simple SIR (susceptible-infected-recovered) model, with susceptible class S, infected class partitioned into severe infections prone to hospitalization (H) and mild, sub-clinical or asymptomatic infections (A). For severe infections prone to hospitalization, we assume that individuals could either recover R, be admitted to the ICU facilities U or or eventually deceased into class D. Since we investigate the cumulative data on the infection classes (and not prevalence), we also include classes C to count cumulatively the new cases for “hospitalized” CH, “asymptomatic” CA, recovered CR and ICU patients CU. The deceased cases are automatically collecting cumulative cases, since there is no exit transition form the deceased class D. For more information, please see also [11]

We consider primarily SHARUCD model versions as stochastic processes in order to compare with the available data which are often noisy and to include population fluctuations, since at times we have relatively low numbers of infected in the various classes. The stochastic version can be formulated through the master equation in application to epidemiology in a generic form using densities of all variables x1S/N, x2H/N, x3A/N, x4R/N, x5U/N, x6CH/N, x7CA/N, x8CU/N and x9D/N and x10CR/N hence state vector x_:=(x1,...,x10)tr, giving the dynamics for the probabilities p(x_,t) as

ddtp(x_,t)=j=1n(Nwj(x_+Δx_j)·p(x_+Δx_j,t)-Nwj(x_)·p(x_,t)) (1)

with n = 10 different transitions wj(x_), as described by the mechanisms above, and small deviation from state x_ as Δx_j:=1N·r_j. For the refined SHARUCD model we have explicitly the following transitions wj(x_) and its shifting vectors r_j given by

w1(x_)=η(1-ν)βx1(x2+ϕx3+ϱ),r_1=(1,-1,0,0,0,-1,0,0,0,0)trw2(x_)=ξ(1-η)βx1(x2+ϕx3+ϱ),r_2=(1,0,-1,0,0,0,-1,0,0,0)trw3(x_)=(1-ξ)(1-η)βx1(x2+ϕx3+ϱ),r_3=(1,0,-1,0,0,0,0,0,0,0)trw4(x_)=γx2,r_4=(0,1,0,-1,0,0,0,0,0,-1)trw5(x_)=(1-ξ)γx3,r_5=(0,0,1,-1,0,0,0,0,0,0)trw6(x_)=γx5,r_6=(0,0,0,-1,1,0,0,0,0,-1)trw7(x_)=ηνβx1(x2+ϕx3+ϱ),r_7=(1,0,0,0,-1,-1,0,-1,0,0)trw8(x_)=μx2,r_8=(0,1,0,0,0,0,0,0,-1,0)trw9(x_)=μx5,r_9=(0,0,0,0,1,0,0,0,-1,0)trw10(x_)=ξγx3,r_10=(0,0,1,-1,0,0,0,0,0,0,-1)tr. (2)

With these wj(x_) and r_j specified we also can express the mean field ODE system.

The deterministic version of the refined model is given by a differential equation system for all classes, including the recording classes of cumulative cases CH, CA, CR and CU by

ddtS=-βSN(H+ϕA+ϱN)ddtH=η(1-ν)βSN(H+ϕA+ϱN)-(γ+μ)HddtA=(1-η)βSN(H+ϕA+ϱN)-γAddtR=γ(H+U+A)ddtU=νηβSN(H+ϕA+ϱN)-(γ+μ)UddtCH=η(1-ν)βSN(H+ϕA+ϱN)ddtCA=ξ·(1-η)βSN(H+ϕA+ϱN)ddtCR=γ(H+U+ξA)ddtCU=νηβSN(H+ϕA+ϱN)ddtD=μ(H+U) (3)

Model parameters and initial conditions are shown in Table 1, where β is the infection rate and ϕ is the ratio describing the asymptomatic/mild infections contribution to the force of infection. γ is the recovery rate, μ is the disease induced death rate and ν is the ratio of hospitalized going to the ICU. η is the proportion of susceptible being infected, develop severe symptoms and being hospitalized whereas 1 − η is the proportion of susceptible becoming infected and developing mild disease or asymptomatic. ξ is the ratio of detected, via testing, mild/asymptomatic infect individuals. ϱ is the import rate needed to describe the introductory phase of the epidemics and for the present study, we assume ϱ to be much smaller than the other additive terms of the force of infection, given the strong observational insecurities on the data collected at the beginning of the outbreak.

Table 1. Model parameters and initial condition values.

Parameters, variables and initial conditions Description Values
N population size 2.2 × 106
H(t0) severe disease and hospitalized 54.0
A(t0) mild disease and asymptomatic 80.0
U(t0) ICU patients 10.0
R(t0) recovered 1.0
CH(t0) recorded H(t0) 54.0
CA(t0) recorded A(t0) 40.0
CU(t0) recorded U(t0) 10.0
CR(t0) recorded R(t0) 1.0
D(t0) death 1.0
β infection rate 3.25 ⋅ γ
ϕ ratio of mild/asymptomatic infections contributing to force of infection 1.65
γ recovery rate 0.05d−1
μ disease induced death rate 0.02d−1
ν hospitalized to ICU rate 0.1
η proportion of hospitalization 0.4
ξ detection ratio of mild/asymptomatic 0.4
ϱ import parameter

Model parameters were estimated and fixed as the model is able to describe the disease incidence during the exponential phase of the outbreak. Parameter values were kept close to the ones found in the literature [1217], used as baseline for initial values and then refined using the available data via the analysis of the likelihood functions [11]. The ratio of mild/asymptomatic infection contribution to the force of infection is estimated to be higher than the contribution of severe hospitalized cases since they would be more mobile and therefore able to transmit the disease while severe cases would be under strict quarantine once detected and admitted to a hospital. We model the effect of transmission of the overall hospitalized individuals and before the hospital admission is notified, symptomatic individuals would contribute significantly to the force of infection. The same assumption is valid for the mild/asymptomatic individuals.

In good agreement, the refined model can describe the hospitalizations, the ICU admissions and the deceased cases, well matched within the median of the 200 stochastic realizations (see Fig 1). The cumulative incidence for all positive cases follows the higher stochastic realizations range and the deviation observed between model simulations and data can be explained by the increasing testing capacities since March 22, 2020, followed by the introduction of rapid tests (blue dots), mostly used as screening tool in nursing homes and public health workers.

0.2 Growth rate

After an introductory phase, the epidemic entered into an exponential growth phase, which started in the Basque Country around the March 10, 2020 and due to the effects of the imposed control measures has left to a slower growth around March 27, 2020 [11]. This exponential growth phase is typical for any outbreak with disease spreading in a completely susceptible population, as observed already in the SIR-system, from the dynamics of the infected dIdt=(βSN-γ)·I when S(t)≈N, such that a linear differential equation dIdt=(β-γ)·I=:λ·I with an exponential growth factor λ is obtained. This growth factor then can be measured again from disease data via λ=1I·dIdt=ddtln(I) giving a straight line in a semi-logarithmic plot of the data.

For larger compartmental models we obtain similarly an exponential growth factor. For the basic SHARUCD model [11] we have the active disease classes H and A with the dynamics given by

ddt(HA)=[(ηβSNϕηβSN(1-η)βSNϕ(1-η)βSN)-((γ+μ+ν)00γ)]·(HA) (4)

now including disease induced transition to death via the mortality rate μ and transition to ICU admission with admission rate ν. For an epidemic in its initial phase, i.e. S(t)≈N, we now have constant matrices B=β(ηϕη(1η)ϕ(1η)) for entries into the disease classes and G=((γ+μ+ν)00γ) for exits from the disease classes, where we had infection rate β and recovery rate γ in the SIR case. With x_=(H,A)tr we now have with J = BG the dynamics ddtx_=Jx_ and its solution

x_(t)=TeΛ(t-t0)T-1x_(t0) (5)

with matrix exponential including the eigenvalue matrix Λ and the transformation matrix T from the eigenvectors of matrix J. The eigenvalues of the matrix J are given by

λ1/2=12·tr±14·tr2-det (6)

with the parameter dependent trace tr = (η + ϕ(1 − η)) ⋅ β − (2γ + μ + ν) and determinant det = γ(γ + μ + ν) − ((γ + μ + ν)ϕ(1 − η) + γη) ⋅ β and the dominating growth factor is given by the largest eigenvalue λ1. After an initial introductory phase the exponential growth with λ1 dominates the dynamics of H(t) and A(t), and from there also all the other variables, because the remaining equations are all inhomogeneous linear differential equations with the inhomogeneities given by the solutions H(t) and A(t), and we have

H(t)KH·eλ1(t-t0),A(t)KA·eλ1(t-t0) (7)

with constants KH and KA depending on parameters and initial conditions (from H(t) = KH,1eλ1(tt0)+ KH,2eλ2(tt0) etc.). In the limiting case of a simple SIR-type model (with ϕ ≈ 1 and μ, νγ) we obtain tr = (η + ϕ(1 − η)) ⋅ β − (2γ + μ + ν) ≈ β − 2γ and det = γ(γ + μ + ν) − ((γ + μ + ν)ϕ(1 − η) + γη) ⋅ βγ2γβ and hence λ1βγ and λ2 ≈ −γ.

The concept of the growth rate can be extended into the phase when effects of the control measures become visible and parameters slowly change, such that for short times the above analysis holds as for constant parameters. The momentary growth rates are analyzed below.

0.3 Reproduction ratio

Another measure of the spreading of the disease in its initial phase is the basic reproduction number (R0), the number of secondary cases Is from a primary case Ip during its infectiveness before recovering in a completely susceptible population.

In its simplest version for SIR models a primary case, Ip(t0) = 1, recovers via dIpdt=-γIp, hence Ip(t) = Ip(t0)eγ(tt0). The number of secondary cases from the primary case is given by dIsdt=βSNIp(t) with Is(t0) = 0, a simple inhomogeneous linear differential equation in case of a entirely susceptible population S(t) = N. The solution is Is(t)=βγ·Ip(t0)(1-e-γ(t-t0))+Is(t0) and gives the total number of secondary cases from a primary case as the long time limit as Is(t)=βγ, hence the basic reproduction number is simply R0=βγ. So we have the relation between R0 and the growth rate λ here as R0=βγ=1+λγ. Generalized, the reproduction ratio is then given by r=Is(t)/Ip(t0)=βγ as the ratio of secondary cases produced by primary cases during their infectiousness.

This concept can be also generalized for larger compartmental models, with the notions of matrices B and G as introduced above. For any primary cases Hp or Ap we have with x_p=(Hp,Ap)tr the decay dynamics ddtx_p=-G·x_p with solution x_p(t)=e-G(t-t0·x_p(t0), using again the matrix exponential. For secondary cases Hs and As we have the dynamics of x_s=(Hs,As)tr given by ddtx_s=B·x_p(t) with solution analogously to the SIR case as x_s(t)-x_s(t0)=BG-1(1-e-G(t-t0))x_p(t0) with F = BG−1 the next generation matrix, since x_s(t)=Fx_p(t0) or from generation x_n to generation x_n+1 the discrete iteration x_n+1=F·x_n. For the present case we have the next generation matrix given as

F=(ηβγ+μ+νϕηβγ(1-η)βγ+μ+νϕ(1-η)βγ) (8)

with its dominant eigenvalue for the basic SHARUCD-model

r1=ηγ+(1-η)ϕ(γ+μ+ν)γ(γ+μ+ν)·β (9)

and the other one being zero. In the limiting case of a simple SIR-type model (with ϕ ≈ 1 and μ, νγ) we obtain again r1 = β/γ as can be easily seen.

This concept of the reproduction ratio can be extended into the phase when effects of the control measures become visible and parameters slowly change. The momentary reproduction ratios (r) can be analyzed, as frequently done for the COVID-19 epidemics, but often called “basic reproduction number”. While the momentary growth rate follows directly from the time continuous data at hand, the momentary reproduction ratio depends on the notion of a generation time γ−1.

To obtain the momentary growth rates from data directly we use λ=ddtln(I) at first applied to the cumulative tested positive cases Icum(t) obtaining, via a smoothing window, the new cases after time τ as

Inew,τ(t):=Icum(t)-Icum(t-τ) (10)

and hence, the growth rate

λ=1Δt(ln(Inew,τ(t))-ln(Inew,τ(t-Δt))). (11)

1 Results and discussion

From the growth rate, the reproduction ratio is calculated with the recovery period γ−1 obtained from our underlying model and recent literature about SARS-CoV-2 interaction with human hosts [1621]. Assuming the recovery period to be of 10 days, we use 7 days smoothing of the differences of logarithmic positive cases to include all possible fluctuations during the data collection process such as “weekend effects”, for example, when we often observe a consistent low number of cases reported that are then adjusted shortly after. For this first exercise, both data sets show negative growth rates from April 1st, 2020, confirming a decrease in disease transmission. Nevertheless, when looking at the long term results for the “Data set A” (see Fig 2a and 2b)), an increase of the growth rate over time is estimated, with values crossing the threshold and becoming positive from April 23 to May 1, 2020, whereas “Data set B” (see Fig 2c and 2d), measures were kept constantly negative, without any signal of increasing disease transmission. The momentary reproduction numbers follow the same trends for both data sets respectively, depending on the data set used. The observed signal from “Data set A” would significantly impact decisions on lockdown lifting, as the national plan for lifting the restrictions imposed during the state of alarm, called “Plan for the Transition towards a new normality”, was announced on April 28, 2020 [22]. Taking place over 4 phases, with a gradual de-escalation to “a new normality”, the plan is dependent on the on-going progress of COVID-19 epidemic’s control across the different regions of Spain. However, results obtained by “Data set B” would, alternatively, support the already started lockdown lifting with its “Phase Zero” initiated on May 4, 2020. When assuming a short recovery period of γ = 4 days, see Fig 4, similar results are observed between the different data sets, only with variation on the absolute values.

Fig 2.

Fig 2

Momentary growth rates estimation from the data on positive tested infected cases in a) PCR and rapid tests and c) PCR alone. The momentary reproduction ratios from the same data respectively are shown in b) and d), for γ−1 = 10.

Fig 4.

Fig 4

Using data on PCR and rapid tests we plot the momentary growth rates estimation from the data on positive tested infected cases (yellow), hospitalizations (red) and ICU admission (purple) are plotted in a) and recovered (green) and deceased cases (black) in b). Using data on PCR tests only we plot the momentary growth rates estimation from the data on positive tested infected cases (yellow), hospitalizations (red) and ICU admission (purple) are plotted in c) and recovered (green) and deceased cases (black) in d).

The momentary growth rates for the various variables are also calculated to verify and support the interpretation of the estimated r(t) threshold behaviour since for any assumed recovery period γ−1, results obtained for the various variables are the same, changing only when considering the different data sets. Fig 4 shows the behavior of three variables that are synchronized in the Basque Country, Icum, CH, and CU. They also cross the threshold to a negative growth rate on April 1st, 2020, confirming the observed r(t) trend obtained by looking at data on Icum alone. Recovered and deceased cases, shown in Fig 4b), follow 1-2 weeks later, due to the delay between onset of symptoms, hospitalization and eventually death, reaching negative growth rate on April 7 and April 11, 2020, respectively. Besides the observed deviation of I, for the “Data set A”, the other variables are kept below the threshold, constantly negative until May 9, 2020, supporting the political decision of starting lifting the lockdown measures rather sooner than later in time. So which measure should be considered to guide political decisions? Here, the answer is simple. When the available data is consistently collected and defined, the momentary growth rates for different variables, I, H, U, R and D, measured directly from the data at hand, should also be considered as complementary investigation.

Conclusion

As the concept of R0 used alone can be easily misinterpreted, specially now when testing capacity is increasing and consequently the number of new notified cases, the BMTF now monitors the development of the COVID-19 epidemic in the Basque Country by considering not only the behaviour of the momentary growth rates λ(t) and momentary reproduction numbers r(t) for the positive cases Icum(t), but also the λ(t) for hospitalizations (CH), ICU admissions (CU), deceased (D) and recovered cases (CR), assisting the Basque Health Managers and the Basque Government with results that are obtained by the model framework, based on available data and evidence as scientific advise. Without interfering in any political decision, we now use “Data set B”, with a clearer definition of tested positive cases Icum and all other variables that follow, CH, CU, CR and D, and recovery period of γ = 4, shown in Figs 3d, 4c and 4d. At the moment, the reproduction ratio r is estimated to be below the threshold behavior of r = 1, but still close to 1, meaning that although the number of new cases reported in the Basque Country are decelerating, the outbreak is still in its linear phase and careful monitoring of the development of the dynamics of the new cases from all categories, based on new information and data, to support the upcoming political decisions that will change the current life situation of millions of people is required.

Fig 3.

Fig 3

Momentary growth rates estimation from the data on positive tested infected cases in a) PCR and rapid tests and c) PCR alone. The momentary reproduction ratios from the same data respectively are shown in b) and d) for γ−1 = 4.

Using the available data for the Basque Country, a small community with short path for data collection and validation, we developed a modeling framework able to predict the course of the epidemic, from introduction to control measure response, potentially helpful for task forces around the globe which are now struggling to provide real scientific advice for health managers and governments while the lockdown measures are relaxed.

Acknowledgments

We thank the huge efforts of the whole COVID-19 BMTF, specially to Eduardo Millán for collecting and preparing the data sets used in this study. We thank Adolfo Morais Ezquerro, Vice Minister of Universities and Research of the Basque Goverment for the fruitful discussions.

Data Availability

The data underlying the results presented in the study are available from https://www.euskadi.eus/boletin-de-datos-sobre-la-evolucion-del-coronavirus/web01-a2korona/es/ Epidemiological data used in this study are provided by the Basque Health Department and the Basque Health Service (Osakidetza) to the Basque Modeling Task Force members, collected with specific inclusion and exclusion criteria. Epidemiological data used in this study are provided by the Basque Health Department and the Basque Health Service (Osakidetza) to the Basque Modeling Task Force members, collected with specific inclusion and exclusion criteria.

Funding Statement

Maíra Aguiar has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 792494.

References

Decision Letter 0

Constantinos Siettos

25 Jun 2020

PONE-D-20-14985

Reproduction ratio and growth rates: measures for an unfolding pandemic

PLOS ONE

Dear Dr. Aguiar,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In the revised version, please also provide  figures with a better resolution of the size of the fonts and labels are too small.

Please submit your revised manuscript by Aug 09 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Constantinos Siettos, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: see attached report

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review-PONE-D-20-14985.pdf

PLoS One. 2020 Jul 23;15(7):e0236620. doi: 10.1371/journal.pone.0236620.r002

Author response to Decision Letter 0


29 Jun 2020

Dear Editor and Reviewer of PloS One Journal,

Thank you for your comments and for allowing us to revise our manuscript. In the revised version we addressed your comments, criticisms and suggestions.

We thank the referee for carefully reading our paper and for the polite tone of making comments. We really appreciated that. A detailed reply on the comments of the reviewer was uploaded separately.

Attachment

Submitted filename: ResponsetoReviewers.pdf

Decision Letter 1

Constantinos Siettos

13 Jul 2020

Reproduction ratio and growth rates: measures for an unfolding pandemic

PONE-D-20-14985R1

Dear Dr. Aguiar,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Constantinos Siettos, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Constantinos Siettos

15 Jul 2020

PONE-D-20-14985R1

Reproduction ratio and growth rates: measures for an unfolding pandemic

Dear Dr. Aguiar:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Constantinos Siettos

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Review-PONE-D-20-14985.pdf

    Attachment

    Submitted filename: ResponsetoReviewers.pdf

    Data Availability Statement

    The data underlying the results presented in the study are available from https://www.euskadi.eus/boletin-de-datos-sobre-la-evolucion-del-coronavirus/web01-a2korona/es/ Epidemiological data used in this study are provided by the Basque Health Department and the Basque Health Service (Osakidetza) to the Basque Modeling Task Force members, collected with specific inclusion and exclusion criteria. Epidemiological data used in this study are provided by the Basque Health Department and the Basque Health Service (Osakidetza) to the Basque Modeling Task Force members, collected with specific inclusion and exclusion criteria.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES